BioSkryb is a venture-backed developer of genomic amplification technologies that deliver unprecedented coverage and fidelity for various gene sequencing applications. Its proprietary genome amplification technology was developed at St. Jude Children's Research Hospital in Memphis, TN.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/09/20 | $11,500,000 | Seed |
Anzu Partners Wilson, Sonsini, Goodrich and Rosati | undisclosed |
